Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow Reinvestment Rate
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Reinvestment Rate of 1.04x as of June 2023, reinvesting €147.33 Million (capex €53.01 Million plus investments €-94.32 Million) from operating cash flow of €141.99 Million. Explore how much does Shanghai Haohai Biological Technology Co reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Haohai Biological Technology Co. Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Shanghai Haohai Biological Technology Co. Ltd across 9 annual periods. Also explore balance sheet size of Shanghai Haohai Biological Technology Co for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Shanghai Haohai Biological Technology Co. Ltd. For live market cap and broader valuation context, see 5HB market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.47x | €951.62 Million | €648.57 Million | €365.49 Million | ▼ -0.4% |
| 2023 | 1.47x | €934.29 Million | €634.45 Million | €343.10 Million | ▼ -56.2% |
| 2022 | 3.36x | €777.76 Million | €231.30 Million | €309.21 Million | ▲ +255.7% |
| 2021 | 0.95x | €323.55 Million | €342.29 Million | €270.88 Million | ▼ -52.3% |
| 2020 | 1.98x | €519.25 Million | €262.07 Million | €189.70 Million | ▼ -26.2% |
| 2019 | 2.68x | €936.19 Million | €348.91 Million | €249.18 Million | ▲ +37.7% |
| 2018 | 1.95x | €762.61 Million | €391.28 Million | €151.21 Million | ▲ +53.2% |
| 2017 | 1.27x | €436.50 Million | €343.06 Million | €134.29 Million | ▼ -79.6% |
| 2016 | 6.24x | €1.59 Billion | €254.49 Million | €75.67 Million | — |